Syros Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Syros Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • Syros Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $11.6M, a 8.97% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $11.6M -$1.14M -8.97% Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $11.9M -$1.09M -8.42% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $12.2M -$1.05M -7.91% Dec 31, 2023 10-Q 2024-07-31
Q3 2023 $12.5M -$1M -7.43% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $12.7M -$956K -6.99% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $13M -$914K -6.58% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $13.2M -$873K -6.19% Dec 31, 2022 10-K 2024-03-27
Q3 2022 $13.5M -$835K -5.84% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $13.7M -$797K -5.5% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $13.9M -$762K -5.2% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $14.1M -$727K -4.9% Dec 31, 2021 10-K 2023-03-02
Q3 2021 $14.3M -$693K -4.62% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $14.5M -$662K -4.37% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $14.7M -$632K -4.13% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $14.8M -$990K -6.26% Dec 31, 2020 10-K 2022-03-15
Q3 2020 $15M -$1.5M -9.12% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $15.1M -$1.69M -10% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $15.3M +$14M +1069% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $15.8M Dec 31, 2019 10-K 2021-03-04
Q3 2019 $16.5M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $16.8M Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $1.31M Mar 31, 2019 10-Q 2019-05-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.